Trial Information

Summary: Male Hot Flash Study

We are currently recruiting men aged 18 and older for a research study to determine the effects of an investigational medication in men with hot flashes as a result of their prostate cancer therapy.

To qualify for the study you must at least meet the conditions listed below:

  • Males, 18 years of age or older
  • Experiencing moderate to severe hot flashes for the past 30 days
  • Treating prostate cancer by one of the following hormone treatments:
    • Have had a bilateral orchiectomy (removal of both testicles) or
    • Using a stable dose of hormone therapy medications

As a qualified study participant, you will receive at no cost:

  • Study-related physical and lab exams
  • Study medication
  • Compensation for your time and travel

For more information call:

Contact:

Advent Clinical Research Centers, Inc.
6161 Dr. Martin Luther King Jr. St. North
Suite 205
St. Petersburg, FL 33703
Telephone: 727-521-9200
Fax: 727-521-9204
Email:

Profile Page: Advent Clinical Research Centers, Inc., St. Petersburg, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:41 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA